Robert Gwozdz has been appointed director of oral formulation at Particle Sciences, Inc. (PSI). Mark Mitchnick, chief executive officer of PSI, said, “PSI has a broad array of drug delivery technologies applicable across many dosage forms and drug types. About 25% of our work is on oral products. The client base now warrants a dedicated director for oral product development. Robert has a vast amount of experience having come from the generics industry and having been key on approximately 30 ANDA...